Patients harboring MPL mutations are also relatively rare, but a meta-analysis unifying seven studies clarified that patients with ET harboring an MPL mutation showed higher risks for thrombosis than those harboring a JAK2V617F mutation [39]. Here, MPL is linked to essential thrombocythemia.